Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Therapeutic management of posttransplant diabetes mellitus.

Author information

Affiliations

  • 1. Transplantation Branch, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institute of Health, Bethesda, MD 20892, USA.
      Authors
    • Mannon RB 1
    (1 author)

ORCIDs linked to this article

Transplantation Reviews (Orlando, Fla.), 01 Apr 2008, 22(2):116-124
https://doi.org/10.1016/j.trre.2007.12.003 PMID: 18631864 

Review

Abstract 

Diabetes mellitus continues to be a common metabolic complication after solid organ transplantation. The etiology is multifactorial and includes both modifiable and nonmodifiable factors. Immunosuppression may play a critical role in its development. Targets of treatment include oral hypoglycemics as well as insulin. More recently, several novel agents have been approved by the Food and Drug Administration for treatment of type 2 diabetes. There is limited experience with these agents in transplant recipients. Use of oral and subcutaneous therapies as well as insulin will be reviewed. As diabetes has a negative impact on patient and graft outcome, the transplant practitioner must be vigilant in screening and managing diabetes after transplantation.

Full text links 

Read article at publisher's site: https://doi.org/10.1016/j.trre.2007.12.003

References 

Articles referenced by this article (80)

Show 10 more references (10 of 80)

Citations & impact 

Impact metrics

6
Citations
Jump to Citations

Citations of article over time

Article citations

Go to all (6) article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.